AU
WGS icon

AlphaGrep UK’s GeneDx Holdings WGS Stock Holding History

AlphaGrep UK’s Portfolio WGS Stock Details WGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238K Buy
+3,470
New +$197K 0.07% 614

Other funds holding WGS

CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

AlphaGrep UK's WGS Position: Q2 2026 in Review

AlphaGrep UK opened a new position in GeneDx Holdings (WGS) in Q2 2026: 3,470 shares worth $238K. The stake represents 0.07% of the portfolio and ranks #614 among its holdings.

204 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • AlphaGrep UK held 3,470 shares of GeneDx Holdings worth $238K as of Q2 2026.
  • GeneDx Holdings was a new AlphaGrep UK position in Q2 2026.
  • GeneDx Holdings made up 0.07% of AlphaGrep UK's portfolio in Q2 2026, its #614 holding.
  • 204 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on AlphaGrep UK's 13F filing for Q2 2026, filed 14 Aug 2026.